Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Return on Capital Employed [ROCE] (2026)

Updated

Odyssey Therapeutics' Return on Capital Employed [ROCE] was -43.62% in Q3 2026, up 8.57 percentage points from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Return on Capital Employed [ROCE] (2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Odyssey Therapeutics came in at -75.85%, down 11.69 percentage points from FY2024.

  • In earlier years, Return on Capital Employed [ROCE] was -64.16% in FY2024 (-16.35 pp) and -47.81% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -43.62%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -43.62%
Jun 30, 2026 -52.19%
Mar 31, 2026 -69.42%
API Access

Odyssey Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ODTX&period=max&api_key=YOUR_API_KEY